¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"product recovery"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® blood product ÇÑ±Û Ç÷¾×Á¦Á¦
¼³¸í   
  1. »ç¶÷ÀÇ Ç÷¾×À» ¼ººÐº°·Î ºÐ¸®ÇÏ¿©, ±×°ÍÀ» ¿ø·á·Î Á¦Á¶ÇÑ ÀǾàǰ. ¾Ç¼º Á¾¾ç µûÀ§¿¡ ¼öÇ÷Çϴ ÀûÇ÷±¸, ¹éÇ÷º´-ÀÚ»ö¹Ýº´ÀÇ ÃâÇ÷À» ¸Ü°ÔÇϴ Ç÷¼ÒÆÇ, È­»óÀÇ Ä¡·á¿¡ ¾²´Â Ç÷Àå, »êÈÄ ÃâÇ÷À» ¸Ü°Ô Çϴ ¼¶À¯¼Ò¿ø µûÀ§°¡ ÀÖ´Ù. 2. »ç¶÷ÀÇ Ç÷¾×ÇüÀ» °Ë»çÇϴµ¥ ¾²´Â ¾à.
¿µ¹® recovery ÇÑ±Û È¸º¹
¼³¸í   
  1. ¼ö¼ú ÈÄ ¶Ç´Â »êÈÄÀǠȯÀÚ°¡ °¢°¢ º´½ÇÀ̳ª º´µ¿ÀÇ °£È£Ã¼Á¦ÇÏ¿¡¼­ ¾ÈÀüÀ» Ã£±â±îÁöÀÇ ±â°£. 2. ¿ÜºÎ·ÎºÎÅÍÀÇ Àڱؿ¡ ÀÇÇØ º¯È­ÇÑ ÈÄ ±× ÀÚ±ØÀÌ Á¦°ÅµÊ°ú µ¿½Ã¿¡ º»·¡ÀÇ »óÅ·ΠµÇµ¹¾Æ°¡´Â ÀÏ. ÀϹÝÀûÀ¸·Î´Â Çѹø »ó½ÇÇÑ °ÍÀ» µÇã´Â °ÍÀ» ¸»ÇÏÁö¸¸, ±Ý¼Ó°øÇп¡¼­´Â °áÁ¤°íü°¡ °¡°øµÊÀ¸·Î½á ±× °íü¿¡ »ý±ä º¯È­°¡ ±× ÈÄÀÇ °¡¿­¿¡ ÀÇÇØ ¿ø·¡ÀÇ ¹æÇâÀ¸·Î µÇµ¹¾Æ°¡´Â °ÍÀ» ¸»ÇÑ´Ù.
¿µ¹® recovery room ÇÑ±Û È¸º¹½Ç
¼³¸í   
  ¼ö¼ú Á÷ÈÄ ÀÏÁ¤±â°£ °£È£¸¦ ¹Þ°Å³ª ¸¶Ãë »óÅ·κÎÅ͠ȸº¹À» Çϱâ À§ÇÏ¿© ¼ö¼úȯÀÚ°¡ ¾ÈÁ¤À» ÃëÇϴ ¹æ. Áï, ¼ö¼ú½Ç¿¡ ÀÎÁ¢ÇÏ¿© Æ¯¼öÇÑ ÀåÄ¡(»ê¼ÒÈíÀÔ, ¼öÇ÷-¼ö¾×, ±âµµÈ®º¸±â±¸ µî)¿Í ÀοøÀ» °®Ãá º´¿øÀÇ ¹æÀ» ¸»ÇÑ´Ù. È°·Â¡ÈĿ͠ÀûÀýÇѠȯ±â´Â È¯ÀÚÀÇ ÀǽÄÀ̠ȸº¹µÉ ¶§ ÁÖÀÇ ±í°Ô °üÂûÇÑ´Ù. È¸º¹½Ç¿¡¼­ Àü´ã ¸¶Ã밣ȣ»ç³ª ¸¶ÃëÀǻ縦 Æ÷ÇÔÇÏ¿© Æ¯º°È÷ ÈƷõȠÀü´ã°£È£»ç¿Í Àåºñ°¡ ÁغñµÇ¾î ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fluid attenuated inversion recovery
    ¾×ü°¨¼è¿ªÀüȸº¹
  • growth recovery line
    ¼ºÀåȸº¹¼±
  • inversion recovery
    ¿ªÀüȸº¹
  • inversion recovery pulse sequence
    ¿ªÀüȸº¹ÆÞ½º¿¬¼â
  • inversion recovery technique
    ¿ªÀüȸº¹±â¹ý
  • postanesthetic recovery
    ¸¶ÃëÈÄȸº¹
  • recovery
    ȸº¹
  • recovery quotient
    ȸº¹Áö¼ö
  • recovery room
    ȸº¹½Ç
  • recovery time
    ȸº¹½Ã°£
  • spontaneous recovery
    ÀÚ¿¬È¸º¹
  • sinus node recovery time
    ±¼°áÀýȸº¹½Ã°£, µ¿°áÀýȸº¹½Ã°£
  • assimilation product
    µ¿È­»ý¼º¹°
  • biological product
    »ý¹°ÇÐÀûÁ¦Á¦
  • blood product
    Ç÷¾×Á¦Á¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • product
    »ý¼º¹°, »ê¹°
  • blood product
    Ç÷¾×Á¦Á¦
  • end product
    ÃÖÁ¾»ê¹°
  • fibrinogen degradation products product
    ¼¶À¯¼ÒºÐÇØ»ê¹°
  • fibrinogen degradation products product
    ¼¶À¯¼Ò¿øºÐÇØ»ê¹°
  • recovery quotient
    ȸº¹Áö¼ö
  • recovery
    ȸº¹
  • recovery roof
    ȸº¹½Ç
  • spontaneous recovery
    ÀÚ¿¬È¸º¹
  • recovery time
    ȸº¹½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fluid attenuated inversion recovery
    ¾×ü°¨¼è¿ªÀüȸº¹
  • growth recovery line
    ¼ºÀåȸº¹¼±
  • inversion recovery
    ¿ªÀüȸº¹
  • inversion recovery technique
    ¿ªÀüȸº¹±â¹ý
  • inversion recovery pulse sequence
    ¿ªÀüȸº¹ÆÞ½º¿¬¼â
  • postanesthetic recovery
    ¸¶ÃëÈÄȸº¹
  • postanesthetic recovery unit
    ¸¶Ãëȸº¹½Ç
  • recovery quotient
    ȸº¹Áö¼ö
  • recovery
    ȸº¹
  • recovery room
    ȸº¹½Ç
  • recovery time
    ȸº¹½Ã°£
  • spontaneous recovery
    ÀÚ¿¬È¸º¹
  • sinus node recovery time
    ±¼°áÀýȸº¹½Ã°£
  • assimilation product
    µ¿È­»ý»ê¹°
  • biological product
    »ý¹°ÇÐÀûÁ¦Á¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • addition product
    ºÎ°¡»ý¼º¹°(¡­ßæà÷Úª).
  • product costing
    Á¦Ç°°¡°Ý»êÁ¤
  • product of metabolism
    ´ë»ç»ê¹°(ÓÛÞóß§Úª).
  • FLAIR(fluid attenuated inversion recovery)
    ¾×ü °¨¾à ¹ÝÀü ȸº¹
  • IR (inversion recovery)
    ¿ªÀü ȸº¹
  • T1 recovery
    T1 ȸº¹
  • growth arrest line (=growth recovery line)
    ¼ºÀå Áö¿¬¼±
  • postanesthetic recovery
    ¸¶ÃëÈÄȸº¹.
  • postanesthetic recovery unit =PARU
    ȸº¹½Ç, ¸¶ÃëÈÄȸº¹À¯´Ö.
  • recovery
    ȸº¹
  • recovery quotient
    ȸº¹Áö¼ö(üáÜÖò¦â¦).
  • recovery room
    ȸº¹½Ç(üáÜÖãø).
  • recovery time
    ȸº¹ ±â°£, ȸº¹ ½Ã°£
  • recovery time
    ȸº¹ ±â°£ (üáÜÖ Ñ¢Êà)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • addition product
    ºÎ°¡»ý¼º¹°(¡­ßæà÷Úª).
  • assimilation product
    µ¿È­»ý»ê¹°.
  • biological product
    »ý¹°ÇÐÀû Á¦Á¦(¡­ð²ð¥).
  • blood product
    Ç÷¾×Á¦Á¦.
  • by-product
    ºÎ»ê¹°.
  • decay product
    ºØ±«»ý¼º
  • degradation product
    ºÐÇØ»ê¹°(ÝÂú°ß§Úª)
  • distortion product otoacoustic emission
    º¯Á¶ÀÌÀ½Çâ¹Ý»ç
  • end product
    ÃÖÁ¾»ê¹°.»ýÈ­Á¾»ê¹°.
  • fibrin degradation product
  • intermediate product
    Áß°£»ý¼º¹°(¡­ßæà÷Úª), Áß°£»ê¹°, Áß°£´ë»ç¹°.
  • ionic product
    ÀÌ¿ÂÀû(¡­îÝ), À̿»깰.
  • metabolic product
    ´ë»ç»ê¹°(¡­ß§Úª).
  • otoacoustic emission, distortion product
    ÀÌÀ½Çâ¹æ»ç¿Ö°î¹°
  • product costing
    Á¦Ç°°¡°Ý»êÁ¤
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • excretory-secretory product
    ºÐºñ¹è¼³¹°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dark recovery
    ¾Ï ȸº¹(äÞüÞÜÖ) (ÔÒ) dark reactivation
  • recovery
    ȸ¼ö(üÞâ¥)
  • recovery heat
    À̿Ͽ­(ì¬èÐæð)
  • recovery time
    ȸ¼ö ½Ã°£(üÞâ¥ãÁÊà)
  • advanced glycosylation end product
    ÁøÇà ´çÈ­Á¾»ê¹°(òäú¼ÓØûùðûß§Úª)
  • Amadori product
    ¾Æ¸¶µµ¸® »ý¼º¹°(ßæà÷Úª)
  • by-product
    ºÎ»ê¹°(Üùß§Úª)
  • end product
    Á¾»ê¹°(ðûß§Úª)
  • end-product inhibition
    Á¾»ê¹° ÀúÇØ (ðûß§ÚªîÁúª)
  • end product repression
    Á¾»ê¹° ¾ïÁ¦ (ðûß§Úªåäð¤)
  • gene product
    À¯ÀüÀÚ(ë¶îîí­) »ê¹°
  • product
    »ê¹°(ß§Úª)
  • product inhibition
    »ê¹°ÀúÇØ(ß§ÚªîÁúª)
  • solubility product
    ¿ëÇØµµ(éÁú°Óø) °ö
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dairy product
    ³«µ¿»ê¹°
  • product
    »ê¹°, »ý¼º¹°
  • FLAIR [=fluid attenuated inversion recovery]
    ¾×ü°¨¾à¹ÝÀüȸº¹
  • fluid attenuated inversion recovery
    ¾×ü°¨¼è¿ªÀüȸº¹
  • inversion recovery [=IR]
    ¿ªÀüȸº¹
  • inversion recovery pulse sequence
    ¿ªÀüȸº¹ÆÞ½º¿¬¼â
  • inversion recovery technique
    ¿ªÀüȸº¹±â¹ý
  • IR [=inversion recovery]
    ¿ªÀüȸº¹
  • recovery
    ȸº¹, ȸ¼öÀ², °¢¼º
  • recovery room
    ȸº¹½Ç
  • recovery time
    ȸº¹±â°£, ȸº¹ ½Ã°£
  • saturation recovery
    Æ÷ȭȸº¹
  • short tau inversion recovery [=STIR]
    ´Ü½Ã°£¹ÝÀüȸº¹
  • STIR [=short tau inversion recovery]
    ´Ü½Ã°£¹ÝÀüȸº¹
  • T1 recovery
    T1ȸº¹
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FDP fibrin degradation product; fibrinogen degradation product; flexor digitorum profundus; frontodextra...
ARP absolute refractory period; American Registry of Pathologists; anticipated recovery path; apolipopro...
PAR participating provider; passive avoidance reaction; perennial allergic rhinitis; photosynthetically ...
RR radiation reaction; radiation response; rate ratio; rational recovery [group]; recovery room; relati...
FSP Fibrin Split Product
  = FDPs
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ARI activation recovery interval
CSNRT Corrected Sinus Node Recovery Time
fast FLAIR Fast fluid attenuated inversion recovery
FAIR Flow sensitive Alternating Inversion Recovery
FLAIR Fluid Attenuated Inversion Recovery
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • autologous blood recovery system
    ÀÚ°¡ Ç÷¾× ȸº¹ ÀåÄ¡
  • fluid attenuated inversion recovery
    ¾×ü °¨¼è ¿ªÀü ȸº¹
  • inversion recovery pulse sequence
    ¿ªÀü ȸº¹ ÆÞ½º ¿¬¼â
  • post-anesthetic recovery
    ¸¶Ãë ÈÄ È¸º¹
  • recovery movement
    º¹±Í ¿îµ¿
  • recovery room
    ȸº¹½Ç
    ¼ö¼ú ÈÄ ¶Ç´Â »êÈÄÀÇ È¯ÀÚ°¡, °¢°¢ º´½ÇÀ̳ª º´µ¿ÀÇ °£È£ üÁ¦ÇÏ¿¡¼­ ¾ÈÀüÀ» ã±â±îÁöÀÇ °£È£¸¦ ¸ñÀûÀ¸·Î ¼ö¼ú½ÇÀ̳ª »ê½Ç¿¡ ÀÎÁ¢ÇÏ¿© Ư¼öÇÑ ÀåÄ¡¿Í ÀοøÀ» °®Ãá º´¿øÀÇ ¹æ.
  • sulfur recovery
    À¯È² ȸ¼ö
  • biological product
    »ý¹°ÇÐÀû Á¦Á¦
  • blood product
    Ç÷¾× Á¦Á¦
  • by-product
    ºÎ»ê¹°, ºÎ»ý¹°
    Áֻ깰À» »ý»êÇÏ´Â °úÁ¤¿¡¼­ »ý±â´Â ÀÌÂ÷Àû »ê¹°.
  • degradation product
    ºÐÇØ »ê¹°
  • distortion product otoacoustic emission
    º¯Á¶ ÀÌÀ½Ç⠹ݻç
  • inflammatory by-product
    ¿°Áõ ºÎ»ê¹°
  • ionic product
    ÀÌ¿ÂÀû, À̿ »ê¹°
  • metabolic waste product
    ´ë»ç ³ëÆó¹°, ´ë»ç »ê¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
product recovery The process of separating a desired recombinant protein from the growth medium and the other elements in the host cells in which it was grown.
(14 Nov 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
anaesthesia recovery period The period of emergence from general anaesthesia, where different elements of consciousness return at different rates.
(12 Dec 1998)
recovery 1. A getting back or regaining; recuperation.
2. Emergence from general anaesthesia.
3. In nuclear magnetic resonance, refers to relaxation.
Origin: M.E., fr. O.Fr. Recoverer, fr. L. Recupero, to recover, get back, fr. Re-, again, + capio, to take
(05 Mar 2000)
recovery boiler A pulp mill boiler in which lignin and spent cooking liquor (black liquor) is burned to generate steam.
(05 Dec 1998)
recovery room Hospital unit providing continuous monitoring of the patient following anaesthesia.
(12 Dec 1998)
recovery score A number expressing the condition of an infant at various stipulated intervals greater than 1 minute after birth and based on the same features assessed by the Apgar score at 60 seconds after birth.
(05 Mar 2000)
materials recovery facility A recycling facility for municipal solid waste.
(05 Dec 1998)
resource conservation and recovery act (RCRA) A federal law regulating solid and hazardous waste. RCRA governs the generation, storage, treatment, transport, and disposal of hazardous waste.
(05 Dec 1998)
creep recovery The time-dependent portion of the decrease in strain in a material or object following removal of the stress that has deformed it.
(05 Mar 2000)
short TI inversion recovery An inversion recovery sequence that uses a short inversion time, about 100 ms., between 180
sinoatrial recovery time <cardiology, physiology> Interval from the last paced P wave to the first succeeding spontaneous P wave (after 2 to 5 minutes of right atrial pacing at 120 to 140 beats per minute, and when expressed as percentage of control cycle length, it normally ranges from 115 to 159%).
(05 Mar 2000)
spontaneous recovery The return of the conditioned response, after apparent extinction, in the presence of the conditioned stimulus without the unconditioned stimulus also being present.
See: classical conditioning.
(05 Mar 2000)
supernormal recovery phase A brief period during the recovery of cardiac muscle following excitation when diseased muscle is more (i.e., less abnormally) excitable; corresponds to the end of the T wave in the ECG.
(05 Mar 2000)
inversion recovery A magnetic resonance pulse sequence in which a series of 180
ultrasonic egg recovery Obtaining an egg for in vitro fertilization by means of an ultrasonically guided needle aspiration of ovarian follicles; may be performed transvesically or via the cul-de-sac.
(05 Mar 2000)
fluorescence recovery after photobleaching Many fluorochromes are bleached by exposure to exciting light. If, for example: the cell surface is labelled with a fluorescent probe and an area bleached by laser illumination, then the bleached patch that starts off as a dark area will gradually recover fluorescence. The recovery is due to the re population of the area by unbleached molecules and diffusion of bleached molecules to other areas. The rate and extent of recovery are a measure of the fluidity of the membrane and the proportion of labelled molecules that are free to exchange with adjacent areas. The technique is usually applied to cell surface fluidity or viscosity measurements, but is also applicable to other structures.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • recovery
    ȸ¼ö
  • European Recovery Program
    ¹Ì±¹ ±¹¹«Àå°ü MarshallÁ¦¾ÈÀÇ À¯·´ ºÎÈï °èȹ
  • enhanced recovery
    =TERTIARY RECOVERY
  • recovery
    µÇã±â;µµ·ÎãÀ½;ȸ¼ö;º¹±¸;(°Ç°­ÀÇ)ȸº¹;¿ÏÄè;¸Å¸³;°£Ã´;°³°£;±Ç¸®ÀÇ È¸º¹;½Â¼Ò
  • recovery room
    (º´¿øÀÇ)ȸº¹½Ç
  • by-product
    ºÎ»ê¹°
  • product
    (º¹¼ö)»ý»ê¹°,¼º°ú
  • end product
    ¿¬¼Ó º¯È­ÀÇ ÃÖÁ¾°á°ú;ÃÖÁ¾ »ý¼º¹°
  • fission product
    Çٺп­ »ý¼º¹°
  • generic product
    »óÇ¥¾øÀÌ ÀϹݸíÀ¸·Î ÆÇ¸ÅµÇ´Â »óǰ
  • gross domestic product
    ±¹³» ÃÑ»÷»ê(GDP)
  • gross national product
    ±¹¹Î ÃÑ»ý»ê D
  • inner product
    ³»Àû
  • national product
    (°æ)(¿¬°£)±¹¹Î»ý»ê(cf.GNP)
  • net domestic product
    ±¹³» ¼ø»ý»ê
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á